Synbiotic-associated improvement in liver function in cirrhotic patients: Relation to changes in circulating cytokine messenger RNA and protein levels

References

• Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with liver cirrhosis. Hepatology 2004; 39: 1441–9
   PubMed Web of Science ®Google Scholar
• Loguercio C, Federico A, Tuccillo C, Terracciano F, D'Auria MV, De Simone C, et al. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol 2005; 39: 540–3
   PubMed Web of Science ®Google Scholar
• Riordan SM, Skinner N, Nagree A, McCallum H, McIver CJ, Kurtovic J, et al. Peripheral blood mononuclear cell expression of Toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology 2003; 37: 1154–64
   PubMed Web of Science ®Google Scholar
• Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, et al. Induction of cachexia in mice by systemically administered myostatin. Science 2002; 296: 1486–8
   PubMed Web of Science ®Google Scholar
• Kovalovich K, DeAngelis RA, Li W, Furth EE, Ciliberto G, Taub R. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 2000; 31: 149–59
   PubMed Web of Science ®Google Scholar
• Hong F, Kim WH, Tian Z, Jaruga B, Ishac E, Shen X, et al. Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene 2002; 21: 32–43
   PubMed Web of Science ®Google Scholar
• Camargo CA, Jr, Madden JF, Gao W, Selvan RS, Clavien PA. Interleukin-6 protects liver against warm ischaemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997; 26: 1513–20
   PubMed Web of Science ®Google Scholar
• Kovalovich K, Li W, DeAngelis R, Greenbaum LE, Ciliberto G, Taub R. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2 and Bcl-xL. J Biol Chem 2001; 276: 26605–13
   PubMed Web of Science ®Google Scholar
• Mizuhara H, Uno M, Seki N, Yamashita M, Yamaoka M, Ogawa T, et al. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 1996; 23: 1608–15
   PubMed Web of Science ®Google Scholar
• Meng ZH, Dyer K, Billiar TR, Tweardy DJ. Distinct effects of systemic infusion of G-CSF vs. IL-6 on lung and liver inflammation and injury in hemorrhagic shock. Shock 2000; 14: 41–8
   PubMed Web of Science ®Google Scholar
• Selzner N, Selzner M, Tian Y, Kadry Z, Clavien PA. Cold ischemia decreases liver regeneration after partial liver transplantation in the rat: a TNF-alpha/IL-6-dependent mechanism. Hepatology 2002; 36: 812–18
   PubMed Web of Science ®Google Scholar
• Sun Z, Klein AS, Radaeva S, Hong F, El-Assal O, Pan H-N, et al. In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology 2003; 125: 202–15
   PubMed Web of Science ®Google Scholar
• Jin X, Zimmers TA, Perez EA, Pierce RH, Zhang Z, Koniaris LG. Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology 2006; 43: 474–84
   PubMed Web of Science ®Google Scholar
• Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274: 1379–83
   PubMed Web of Science ®Google Scholar
• Ganslmayer M, Ocker M, Zopf S, Schuppan D, Hahn EG, Herold C. Hepatocellular carcinomas do not compromise quantitative tests of liver function. Hepatogastroenterology 2005; 52: 881–4
   Google Scholar
• Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 2005; 12: 16–22
   PubMedGoogle Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646–9
   PubMed Web of Science ®Google Scholar
• Manrekar P, Catalano D, Szabo G. Alcohol-induced regulation of nuclear regulatory factor-kappa beta in human monocytes. Alcohol Clin Exp Res 1997; 21: 1226–31
   Web of Science ®Google Scholar
• Enomoto N, Ikejima K, Bradford B, Rivera C, Kono H, Brenner DA, et al. Alcohol causes both tolerance and sensitisation of rat Kupffer cells via mechanisms dependent on endotoxin. Gastroenterology 1998; 115: 443–51
   PubMed Web of Science ®Google Scholar
• Sakka SG, Reinhart K, Meier-Hellmann A. Comparison of invasive and noninvasive measurements of indocyanine green plasma disappearance rate in critically ill patients with mechanical ventilation and stable hemodynamics. Intensive Care Med 2000; 26: 1553–6
   PubMed Web of Science ®Google Scholar
• Faybik P, Krenn C-G, Baker A, Lahner D, Berlakovich G, Steltzer H, et al. Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: a prospective investigator-blinded study. Liver Transpl 2004; 10: 1060–4
   PubMed Web of Science ®Google Scholar
• Kruse N, Pette M, Toyka K, Rieckmann P. Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood. J Immunol Methods 1997; 210: 195–203
   PubMed Web of Science ®Google Scholar
• Starkie RL, Arkinstall MJ, Koukoulas I, Hawley JA, Febbraio MA. Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. J Physiol 2001; 553: 585–91
   Google Scholar
• Tilg H, Vogel W, Wiedermann CJ, Shapiro L, Herold M, Judmaier G, et al. Circulating interleukin 1 and tumor necrosis factor antagonists in liver disease. Hepatology 1993; 18: 1132–8
   PubMed Web of Science ®Google Scholar
• Diez-Ruiz A, Tilz GP, Gutierrez-Gea F, Gil-Extremera B, Murr C, Wachter H, et al. Neopterin and soluble tumor necrosis factor receptor type 1 in alcoholic cirrhosis. Hepatology 1995; 21: 976–8
   PubMed Web of Science ®Google Scholar
• Lee FY, Lu RH, Tsai YT, Lin HC, Hou MC, Li CP, et al. Plasma interleukin-6 levels in patients with cirrhosis. Scand J Gastroenterol 1996; 31: 500–15
   PubMed Web of Science ®Google Scholar
• Enomoto N, Ikejima K, Yamashina S, Hirose M, Shimizu H, Kitamura T, et al. Kupffer cell sensitization by alcohol involves increased permeability to gut-derived endotoxin. Alcohol Clin Exp Res 2001; 25(6 Suppl)51S–54
   Web of Science ®Google Scholar
• Wheeler MD. Endotoxin and Kupffer cell activation in alcoholic liver disease. Alcohol Res 2003; 27: 300–6
   Web of Science ®Google Scholar
• Morita T, Tanabe H, Takahashi K, Sugiyama K. Ingestion of resistant starch protects endotoxin influx from the intestinal tract and reduces D-galactosamine-induced liver injury in rats. J Gastroenterol Hepatol 2004; 19: 303–13
   Web of Science ®Google Scholar